The MHRA "Custom-Made" Regulatory Pathway
The Medicines and Healthcare products Regulatory Agency (MHRA) has established a specific regulatory framework in 2026 to govern 3D-printed implants produced within hospital settings. Since these devices are unique to each patient, they cannot be tested via traditional clinical trials.
The MHRA framework focuses on the Validation of the Digital Workflow. This includes certifying the software used for anatomical segmentation, the purity of the medical-grade metal powders, and the "Post-Processing" sterilization protocols. This regulatory clarity has allowed the UK to lead in "Point-of-Care" manufacturing, ensuring that a custom-printed jawbone or spinal cage meets the same safety and quality standards as any mass-produced medical device.
1 View